1019 QTs
BioCentury & Getty Images

Deals

Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta    

Oct 20, 2020 | 1:38 AM GMT

Genesis and Genentech collaborate to identify drug candidates using AI
Stanford spinout and AI platform company Genesis Therapeutics Inc. entered into

Read the full 448 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE